Mergers & Acquisitions Mergers & Acquisitions

Comment: CVS Health’s vertical deal for Signify Health could raise entry barrier, market power concerns

By Flavia Fortes
  • 08 Sep 2022 20:29
  • 08 Sep 2022 20:29
CVS Health’s $8 billion bid for home care provider Signify Health could attract antitrust scrutiny over entry barriers and the companies’ strengthened position in the healthcare market.
Even though the companies say there are no overlapping businesses between them, antitrust regulators have been wary of market consolidation in general, particularly

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Flavia Fortes

Global Head of Mergers

Flavia writes about merger control, antitrust enforcement and litigation in the U.S. and Brazil. Before joining MLex, Flavia worked as an Antitrust Consultant in the Federal Trade Commission's Office of International Affairs and as a Research Fellow for the American Antitrust Institute. She has written on the intersection of antitrust law and intellectual property law in technology-driven and innovative markets.

Discover MLex

Stay on top of global regulatory developments

Latest News